Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
61%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
THNR
19
HOLDINGS
79%
ALSO IN OZEM
OZEM
22
HOLDINGS
71%
ALSO IN THNR
SECTOR DRIFT (THNR minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
NOVO-NORDISK A/S-SPONS ADR | 14.6% | 22.5% | 14.6% |
 |
ELI LILLY & CO | 12.3% | 14.8% | 12.3% |
 |
ROCHE HOLDING LTD | 5.2% | 4.2% | 4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 6.5% | 3.9% | 3.9% |
|
PFIZER INC | 4.7% | 3.8% | 3.8% |
THNR Overweight Relative to OZEM
|
MERCK & CO. INC. | 5.1% |
|
ABBVIE INC | 4.6% |
|
SHIONOGI & CO LTD | 4.0% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.8% |
|
REGENERON PHARMACEUTICALS | 3.7% |
|
AMGEN INC | 3.3% |
|
HIMS & HERS HEALTH, INC. CLASS A | 2.8% |
|
CHUGAI PHARMACEUTICAL CO LTD | 2.6% |
 |
CHINA PHARMACEUTICAL GROUP | 2.2% |
 |
ASTRAZENECA PLC-SPONS ADR | 1.8% |
THNR Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -7.9% |
 |
ASCLETIS PHARMA, INC. | -3.9% |
 |
SHANGHAI FOSUN PHARMACEUTI-H | -3.1% |
|
ELI LILLY & CO | -2.4% |
 |
HANMI PHARM CO LTD | -2.4% |
|
VIKING THERAPEUTICS, INC. | -2.2% |
|
ZEALAND PHARMA A/S | -1.9% |
|
GILEAD SCIENCES INC | -1.9% |
|
THE UNITED LABORATORIES INTE | -1.9% |
|
RHYTHM PHARMACEUTICALS, INC. | -1.3% |